Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-05-03

FDA Approved: NITROGLYCERIN — Original Application (Advagen Pharma Ltd)

View source ↗

Summary

FDA approved Advagen Pharma Ltd's generic nitroglycerin under an Original Application (ANDA 209779), enabling marketing of the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NITROGLYCERIN (Nitroglycerin)

Snippet

ORIG AP for NITROGLYCERIN (NITROGLYCERIN)